abrdn Healthcare Investors, abrdn Life Sciences Investors, abrdn Healthcare Opportunities Fund and abrdn World Healthcare Fund are asking shareholders to elect trustees at joint annual meetings on May 27, 2026. Each fund will vote on two trustee nominees whose new staggered terms would run until the 2029 annual meeting.
Shareholders of record as of April 1, 2026 can vote by mail, phone, internet or in person in Philadelphia. The boards, which are majority independent and chaired by independent trustee Todd Reit, recommend voting “FOR” all nominees. KPMG LLP remains the independent registered public accounting firm, and detailed information on trustee backgrounds, fund ownership, audit fees and trustee compensation is provided to support voting decisions.
An officer of abrdn Healthcare Investors, serving as a vice president, filed an initial insider ownership report for HQH as of 12/09/2025. The filing states that no securities of abrdn Healthcare Investors are beneficially owned by this reporting person. The report is filed by a single reporting person and is accompanied by a power of attorney authorizing the signatory.